Quick Answer
Park Ha Biological Technology Co., Ltd. reported Total Revenue of $2.52 million for fiscal year 2025.
Park Ha Biological Technology Co., Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $2.52M +6.0% |
$2.38M -3.1% |
$2.46M +28.1% |
$1.92M | — |
| Net Income | -$24.36M -5191.3% |
$478.6K -43.8% |
$852.0K +345.4% |
$191.3K | — |
| Diluted EPS | -$41.38 -4410.4% |
$0.96 -43.5% |
$1.70 +16900.0% |
$0.01 | — |
| Total Assets | $5.95M +93.1% |
$3.08M +36.1% |
$2.26M | — | — |
| Cash and Equivalents | $3.79M +591.8% |
$547.5K -47.0% |
$1.03M | — | — |
| Stockholders Equity | $3.99M +165.2% |
$1.51M +48.8% |
$1.01M +573.7% |
$150.3K +126.0% |
-$578.2K |
| R&D Expense | $238.2K +548.8% |
$36.7K +18.9% |
$30.9K -49.1% |
$60.7K | — |
| Operating Income | -$24.15M -3142.5% |
$793.7K -32.8% |
$1.18M +499.2% |
$197.0K | — |
| Gross Profit | $2.38M +9.0% |
$2.19M +1.8% |
$2.15M +52.3% |
$1.41M | — |
| Shares Outstanding | — | 25.00M +0.0% |
25.00M | — | — |
- Park Ha Biological Technology Co., Ltd. reported Total Revenue of $2.52 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +6.0% in Total Revenue compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Net Income of -$24.36 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed a decrease of -5191.3% in Net Income compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Diluted EPS of $41.38 per share (loss) for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed a decrease of -4410.4% in Diluted EPS compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Total Assets of $5.95 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +93.1% in Total Assets compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Cash and Equivalents of $3.79 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +591.8% in Cash and Equivalents compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Stockholders Equity of $3.99 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +165.2% in Stockholders Equity compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported R&D Expense of $238.2 thousand for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +548.8% in R&D Expense compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Operating Income of -$24.15 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed a decrease of -3142.5% in Operating Income compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Gross Profit of $2.38 million for fiscal year 2025.
- Park Ha Biological Technology Co., Ltd. showed an increase of +9.0% in Gross Profit compared to the prior fiscal year.
- Park Ha Biological Technology Co., Ltd. reported Shares Outstanding of 25.00 million shares for fiscal year 2024.
- Park Ha Biological Technology Co., Ltd. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: